PAREXEL INTERNATIONAL TO PRESENT AT UBS WARBURG GLOBAL HEALTHCARE SERVICES CONFERENCE
BOSTON, MA, January 29, 2003 — PAREXEL International Corporation (Nasdaq: PRXL) announced today it will be presenting at the UBS Warburg Global Healthcare Services Conference at The Plaza Hotel in New York City. Josef von Rickenbach, Chairman and Chief Executive Officer, and James Winschel, Senior Vice President and Chief Financial Officer will be making a formal presentation on PAREXEL at 1:00 p.m. EST on Monday, February 3rd.
The presentation will be broadcast live over the internet at http://www. parexel.com. To access the webcast, please visit the “Webcasts” page of the Investor Relations section of the Company’s website at least fifteen minutes prior to the scheduled presentation to register, download and install the necessary software. After the conference, the webcast will be archived and available for 30 days.
PAREXEL is one of the largest biopharmaceutical outsourcing organizations in the world, providing a broad range of knowledge-based contract research, medical marketing and consulting services to the worldwide pharmaceutical, biotechnology and medical device industries. With a commitment to providing solutions that expedite time-to-market and peak market penetration, PAREXEL has developed significant expertise in clinical trials management, data management, biostatistical analysis, medical marketing, clinical pharmacology, regulatory and medical consulting, industry training and publishing and other drug development consulting services. Its information technology subsidiary, Perceptive Informatics, Inc., provides a variety of technology products and services, including web-based portal solutions and voice and data systems, and the use and interpretation of medical images as clinical trial endpoints, which are designed to accelerate and enhance the clinical development and launch processes. The Company’s integrated services, therapeutic area depth and sophisticated information technology, along with its experience in global drug development and product launch services, represent key competitive strengths. Headquartered near Boston, MA, PAREXEL operates in 58 locations throughout 35 countries around the world, and has approximately 4,970 employees.